BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10331514)

  • 1. Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells.
    Wimazal F; Sperr WR; Horny HP; Carroll V; Binder BR; Fonatsch C; Walchshofer S; Födinger M; Schwarzinger I; Samorapoompichit P; Chott A; Dvorak AM; Lechner K; Valent P
    Am J Hematol; 1999 May; 61(1):66-77. PubMed ID: 10331514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
    Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
    Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
    Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
    Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.
    Horny HP; Valent P
    Leuk Res; 2001 Jul; 25(7):543-51. PubMed ID: 11377679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
    Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
    Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
    Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
    J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
    Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
    Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
    Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
    J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
    Wimazal F; Walchshofer S; Baghestanian M; Chott A; Sperr WR; Kopp C; Sillaber C; Semper H; Horny HP; Tröndle U; Födinger M; Schwarzinger I; Lechner K; Valent P
    Wien Klin Wochenschr; 1998 Feb; 110(3):79-88. PubMed ID: 9553202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping.
    Agis H; Beil WJ; Bankl HC; Füreder W; Sperr WR; Ghannadan M; Baghestanian M; Sillaber C; Bettelheim P; Lechner K; Valent P
    Leuk Lymphoma; 1996 Jul; 22(3-4):187-204. PubMed ID: 8819068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
    Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
    Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes.
    Ribatti D; Polimeno G; Vacca A; Marzullo A; Crivellato E; Nico B; Lucarelli G; Dammacco F
    Leukemia; 2002 Sep; 16(9):1680-4. PubMed ID: 12200681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional characterization of mast cells derived from renal tumor tissues.
    Beil WJ; Füreder W; Wiener H; Grossschmidt K; Maier U; Schedle A; Bankl HC; Lechner K; Valent P
    Exp Hematol; 1998 Feb; 26(2):158-69. PubMed ID: 9472805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
    Samorapoompichit P; Schernthaner GH; Worda C; Wimazal F; Krauth MT; Sperr WR; Valent P
    Histopathology; 2006 Feb; 48(3):247-57. PubMed ID: 16430471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.
    Sperr WR; Drach J; Hauswirth AW; Ackermann J; Mitterbauer M; Mitterbauer G; Foedinger M; Fonatsch C; Simonitsch-Klupp I; Kalhs P; Valent P
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6787-92. PubMed ID: 16203765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
    Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
    Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
    Zheng Y; Nong L; Liang L; Wang W; Li T
    Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.